Results 201 to 210 of about 400,239 (293)

Biophysical analysis of angiotensin II and amyloid-β cross-interaction in aggregation and membrane disruption. [PDF]

FEBS Lett
Habibnia M, Catalina-Hernandez E, Cabrerizo-Idiazabal M, Barnadas-Rodríguez R, Lopez-Martin M, Peralvarez-Marin A.   +5 more
europepmc   +1 more source

The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats. [PDF]

, 1995
Gretchen S. Crary, Suzanne K. Swan, Michael P. O’Donnell, Bertram L. Kasiske, Stephen A. Katz, W. F. Keane   +5 more
openalex   +1 more source

Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers. [PDF]

Int J Mol Sci
Chatzipieris FP, Mavromoustakou K, Matsoukas JM, Mavromoustakos T.   +3 more
europepmc   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II. [PDF]

J Burn Care Res
Mueller SW, Tran NM, Betthauser KD, Buckley MS, Shupp J, Wiktor AJ, Hill DM.   +6 more
europepmc   +1 more source

Salt‐Sensitive Hypertension Resulting From Nitric Oxide Synthase Inhibition is Associated with Loss of Regulation of Angiotensin II in the Rat [PDF]

, 2002
George Hodge, V. Z. C. Ye, Katherine A. Duggan   +2 more
openalex   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Angiotensin II signal transduction pathways in chick cardiomyocytes: involvement of tyrosine phosphorylation

, 2009
Valeri Goutsouliak
openalex   +1 more source

Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells.

, 2020
Alejandra Sousa-Lopes, Raiany Alves de Freitas, Fernando S. Carneiro, Kênia Pedrosa Nunes, Kyan James Allahdadi, R. Clinton Webb, Rita C. Tostes, Fernanda R. Giachini, Victor V. Lima   +8 more
openalex   +1 more source

Adrenomedullin Inhibits Angiotensin II–Induced Expression of Tissue Factor and Plasminogen Activator Inhibitor-1 in Cultured Rat Aortic Endothelial Cells [PDF]

, 2001
T Sugano, Hajime Tsuji, Haruchika Masuda, Hiromi Nishimura, M Yoshizumi, Hidehiko Kawano, Shinzo Kimura, Naoki Ukimura, Shingo Yano, Y. Kunieda, Keigo Nakagawa, Masao Nakagawa   +11 more
openalex   +1 more source